IP Library › Granted Patent US 9,446,104
Granted Patent B2
US 9,446,104 · App. 14/132,962 · Granted Sep 20, 2016

Method of inducing a proinflammatory immune response to human α-lactalbumin

Inventors: Vincent K. Tuohy (Broadview Heights, OH); Justin M. Johnson (Willoughby Hills, OH); Ritika Jaini (Cleveland, OH)
Assignee: The Cleveland Clinic Foundation
A61K39/0011A61K2039/545A61K2039/55577A61K2039/572
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,446,104
App. No.
14/132,962
Granted
Sep 20, 2016
Kind
B2
Abstract

Compositions and methods for immunization against human breast cancer are disclosed. A breast cancer vaccine comprises an immunogenic polypeptide comprising human α-lactalbumin.

Claims (7)

1. A method of inducing production of IFNγ by purified human female CD4+ or CD8+ T cells, said method comprising the step of exposing purified human female antigen presenting cells to an antigen consisting of recombinant human α-lactalbumin as set forth in SEQ ID NO: 1 in the presence of purified human female CD4+ or CD8+ T cells, wherein said exposing step activates said purified human female CD4+ or CD8+ T cells, thereby inducing production of IFNγ by the purified human female CD4+ or CD8+ T cells.

2. The method of claim 1 , wherein the antigen presenting cells comprise dendritic cells.

3. The method of claim 2 , wherein the dendritic cells are prepared from peripheral blood mononuclear cells isolated from a human female.

4. The method of claim 1 , wherein the human female CD4+ or CD8+T cells comprise purified unprimed CD4+ or CD8+T cells from a human female.

5. The method of claim 4 , wherein the human female CD4+ or CD8+T cells comprise CD4+T cells.

6. The method of claim 4 , wherein the human CD4+ or CD8+T cells comprise CD8+ T cells.

7. The method of claim 1 , wherein the recombinant α-lactalbumin is produced in Escherichia coli.

Assignments (5)
CONFIRMATORY LICENSE Recorded Jun 4, 2020
From: CLEVELAND CLINIC FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 052833/0927 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE: THE CLEVELAND CLINIC PREVIOUSLY RECORDED ON REEL 036185 FRAME 0897. ASSIGNOR(S) HEREBY CONFIRMS THE THE CLEVELAND CLINIC FOUNDATION. Recorded May 19, 2016
From: JOHNSON, JUSTIN M.; JAINI, RITIKA
To: THE CLEVELAND CLINIC FOUNDATION
Reel/Frame 038755/0989 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED AT REEL: 036253 FRAME: 0855. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded May 19, 2016
From: TUOHY, VINCENT K.
To: THE CLEVELAND CLINIC FOUNDATION
Reel/Frame 038756/0136 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2015
From: TUOHY, VINCENT K.
To: THE CLEVELAND CLINIC
Reel/Frame 036253/0855 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 27, 2015
From: JOHNSON, JUSTIN M.; JAINI, RITIKA
To: THE CLEVELAND CLINIC
Reel/Frame 036185/0897 →
Continuity (5)
Division 13157990 · Jun 10, 2011
Provisional Application 61353464 · Jun 10, 2010
Provisional Application 61353470 · Jun 10, 2010
Provisional Application 61353825 · Jun 11, 2010
Related Publication 20140178418A1 · Jun 26, 2014